AMS Technologies Agrees On Distribution of High Power LED For All EC Countries

AMS Technologies AG, a Pan-European distributor of high-tech components and systems, and Enfis Ltd., a British manufacturer of semiconductor based light source modules and systems, have signed a distribution agreement for all EC countries.

The agreement comprises intelligent, high-power light emitting diodes (LED) arrays and smart light engines across a wide range of wavelengths.

Founded in 2001 as a spin-out from Swansea University, which has a long history of innovation in the handling of power devices and the thermal management of semi conductor devices, Enfis uses the latest advances in semiconductor optoelectronic device fabrication, thermal management and optical design technologies.

Enfis’ product lines combine the numerous advantages of LED's as a light source with a patent-pending thermal management technology for use in a number of challenging applications, including medical and dental applications, industrial and aerospace lighting, entertainment lighting, architectural lighting, projection and LCD, sensing and curing.
 

Posted March 18th,2008

Citations

Please use one of the following formats to cite this article in your essay, paper or report:

  • APA

    AMS Technologies AG. (2019, February 10). AMS Technologies Agrees On Distribution of High Power LED For All EC Countries. AZoM. Retrieved on November 10, 2024 from https://www.azom.com/news.aspx?newsID=11607.

  • MLA

    AMS Technologies AG. "AMS Technologies Agrees On Distribution of High Power LED For All EC Countries". AZoM. 10 November 2024. <https://www.azom.com/news.aspx?newsID=11607>.

  • Chicago

    AMS Technologies AG. "AMS Technologies Agrees On Distribution of High Power LED For All EC Countries". AZoM. https://www.azom.com/news.aspx?newsID=11607. (accessed November 10, 2024).

  • Harvard

    AMS Technologies AG. 2019. AMS Technologies Agrees On Distribution of High Power LED For All EC Countries. AZoM, viewed 10 November 2024, https://www.azom.com/news.aspx?newsID=11607.

Tell Us What You Think

Do you have a review, update or anything you would like to add to this news story?

Leave your feedback
Your comment type
Submit

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.